Credit Suisse Ag Personalis, Inc. Transaction History

Credit Suisse Ag

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Aug 12, 2022	SELL	$3.27 - $8.76 $78,427 - $210,099	-23,984 Reduced 99.92%	19 $0
Q1 2022 May 16, 2022	SELL	$7.56 - $14.3 $10,977 - $20,763	-1,452 Reduced 5.7%	24,003 $197,000
Q4 2021 Feb 14, 2022	BUY	$12.24 - $21.25 $4,198 - $7,288	343 Added 1.37%	25,455 $363,000
Q3 2021 Nov 12, 2021	BUY	$16.69 - $26.05 $123,138 - $192,196	7,378 Added 41.6%	25,112 $485,000
Q2 2021 Aug 16, 2021	BUY	$18.15 - $27.75 $19,710 - $30,136	1,086 Added 6.52%	17,734 $449,000
Q1 2021 May 14, 2021	SELL	$20.71 - $51.02 $109,162 - $268,926	-5,271 Reduced 24.05%	16,648 $410,000
Q4 2020 Feb 12, 2021	BUY	$21.84 - $44.0 $478,710 - $964,436	21,919 New	21,919 $802,000

109

30.9M

16.9K

90.8K

Ticker PSNL
Exchange NASDAQ
Sector Healthcare
Industry Diagnostics & Research
Shares Outstandng 45,918,400
Market Cap $253M
Description
Personalis, Inc. operates as a cancer genomics company worldwide. The company provides sequencing and data analysis services to support the development of cancer therapies and large-scale genetic research programs. It offers NeXT Platform, which provides data analysis for tumor and its immune microenvironment, from a single limited tissue or pla...

Get notified when there are updates to the investment portfolio of Credit Suisse Ag, based on Form 13F filings with the SEC.

Stay updated on Credit Suisse Ag with notifications on news.